[1]严 威,靳 情.医院内泌尿道感染患者的病原菌耐药性分析[J].医学信息,2018,31(11):118-120.[doi:10.3969/j.issn.1006-1959.2018.11.037]
 YAN Wei,JIN Qing.Analysis of Pathogenic Bacteria Resistance of Patients with Urinary Tract Infection in Hospital[J].Journal of Medical Information,2018,31(11):118-120.[doi:10.3969/j.issn.1006-1959.2018.11.037]
点击复制

医院内泌尿道感染患者的病原菌耐药性分析()
分享到:

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
31卷
期数:
2018年11期
页码:
118-120
栏目:
调查分析
出版日期:
2018-06-01

文章信息/Info

Title:
Analysis of Pathogenic Bacteria Resistance of Patients with Urinary Tract Infection in Hospital
文章编号:
1006-1959(2018)11-0118-03
作者:
严 威1靳 情2
1.湖北医药大学附属襄阳市第一人民医院输血科,湖北 襄阳 441000; 2.湖北中医药大学附属襄阳市中医医院检验科,湖北 襄阳 441000
Author(s):
YAN Wei1JIN Qing2
1.Blood Transfusion Section,First People's Hospital of Xiangyang,Hubei Medical University,Xiangyang 441000,Hubei,China; 2.Department of Clinical Laboratory,Xiangyang Municipal Chinese Medicine Hospital Affiliated to Hubei University of Traditional Chinese Medicine,Xiangyang 441000,Hubei,China
关键词:
获得性泌尿系统感染抗菌药物病原菌
Keywords:
Key words:Acquired urinary tract infectionAntimicrobial agentsPathogenic bacteria
分类号:
R446.5
DOI:
10.3969/j.issn.1006-1959.2018.11.037
文献标志码:
A
摘要:
目的 了解湖北省襄阳市第一人民医院住院患者泌尿系感染的主要病原菌分布与抗生素对常用菌的 耐药率。方法 回顾性收集湖北省襄阳市第一人民医院2017年1月~12月住院患者1580份尿培养样本,采用全自动微生物鉴定仪480份阳性标本进行鉴定及药敏试验。应用WHONET5.6对数据进行分析。结果 480株病原菌中,革兰阴性杆菌353株(73.54%),以大肠埃希菌、肺炎克雷伯菌和铜绿假单胞菌为主;革兰阳性球菌85株占(17.71%),以肠球菌和凝固酶阴性葡萄球菌为主;真菌40株(8.33%)。检出的病原菌对各种抗生素的耐药率不同,所有分离的大肠埃希菌与肺炎克雷伯菌对三代头孢菌素和喹诺酮类耐药率均大于50%,并且外科系统分离的大肠埃希菌株耐药率高于内科系统;铜绿假单胞菌对β内酰胺酶抑制剂耐药率大于30%,高于其他病原菌对此类抗生素耐药率。未发现分离的革兰阳性菌对万古霉素和利奈唑胺耐药,凝固酶阴性葡萄球菌对苯唑西林耐药率达82.60%。结论 本院泌尿系统感染中,以大肠埃希菌感染为主,β内酰胺酶抑制剂可用于大肠埃希菌和肺炎克雷伯菌常规治疗。
Abstract:
Abstract:Objective To investigate the distribution of main pathogens of urinary tract infection and antibiotic resistance to commonly used bacteria in inpatients of Xiangyang first people's hospital of Hubei province.Methods A retrospective collection of 1580 urine culture samples of hospitalized patients from January to December 2017 in the first people's hospital of Xiangyang city,Hubei province was conducted.480 positive specimens were used for identification and drug susceptibility testing.Apply WHONET5.6 to analyze the data.Results Among the 480 pathogenic bacteria,353 strains of gram-negative bacilli(73.54%)were Escherichia coli, Klebsiella pneumoniae and Pseudomonas aeruginosa,85 of gram-positive cocci(17.71%),Enterococcus and coagulase negative staphylococcus,40 fungi(8.33%),were mainly Enterococcus and coagulase negative Staphylococcus.The resistance rates of pathogenic bacteria to all kinds of antibiotics were different.The resistance rate of all isolated Escherichia coli and Klebsiella pneumoniae to three generation cephalosporins and quinolones was more than 50%,and the resistance rate of Escherichia coli isolated from the surgical system was higher than that in the internal medicine system;The resistance rate of Pseudomonas aeruginosa to β lactamase inhibitors is more than 30%,which is higher than that of other pathogens.No gram positive bacteria isolated were resistant to vancomycin and linezolid,and the resistance rate of clotting negative staphylococci to oxacillin was 82.60%.Conclusion Escherichia coli is the main infection in the urinary tract infection in our hospital,and the β lactamase inhibitor can be used for routine treatment of Escherichia coli and Klebsiella pneumoniae.

参考文献/References:

[1]王宏儒,鲍晓荣,袁轶群.尿路感染患者病原菌分布及其耐药性分析[J].中华医院感染学杂志,2014,24(8):1859-1861. [2]李珍,李从荣,蔡璇,等.武汉地区泌尿道感染病原菌的分布及耐药性分析[J].现代检验医学杂志,2014,29(5):135-137. [3]那彦群,叶章群,孙光,等.2011版中国泌尿外科疾病诊断治疗指南手册[M].1版.北京:人民卫生出版社,2011. [5]朱德妹,汪复,胡付品,等.2010年中国CHINET尿液标本中细菌的分布和耐药性监测[J].中国感染与化疗杂志,2012,12(4):241-250. [6]张树琛,鲁炳怀,朱凤霞.尿培养病原菌分布及其耐药分析[J].实用医技杂志,2014,21(4):370-372. [7]李晖婷,刘霞,蔡小华.403例尿培养分离病原菌的耐药性检测[J].中华医院感染学杂志,2013,23(9):2236-2238.

相似文献/References:

[1]尹利娟,杨振华,杨乐园.2014~2016年嗜麦芽窄食单胞菌感染临床分布及耐药性分析[J].医学信息,2018,31(03):128.[doi:10.3969/j.issn.1006-1959.2018.03.044]
 YIN Li-juan,YANG Zhen-hua,YANG Le-yuan.Clinical Distribution and Drug Resistance Analysis of Stenotrophomonas Maltophilia Infection from 2014 to 2016[J].Journal of Medical Information,2018,31(11):128.[doi:10.3969/j.issn.1006-1959.2018.03.044]
[2]孙 赟,朱振国,余春兰,等.基于电子病历系统的抗菌药物分级管理系统开发及应用[J].医学信息,2018,31(07):18.[doi:10.3969/j.issn.1006-1959.2018.07.006]
 SUN Yun,ZHU Zhen-guo,YU Chun-lan,et al.Development and Application of Antibiotic Grading Management System Based on Electronic Medical Record System[J].Journal of Medical Information,2018,31(11):18.[doi:10.3969/j.issn.1006-1959.2018.07.006]
[3]曹 蕾.医院信息化管理系统促进抗菌药物合理使用的价值分析[J].医学信息,2018,31(17):31.[doi:10.3969/j.issn.1006-1959.2018.17.010]
 CAO Lei.Value Analysis of Hospital Information Management System Promoting Rational Use of Antimicrobial Agents[J].Journal of Medical Information,2018,31(11):31.[doi:10.3969/j.issn.1006-1959.2018.17.010]
[4]王永艳,鱼兆虎.抗菌药物审批管理软件的设计与实现[J].医学信息,2019,32(12):21.[doi:10.3969/j.issn.1006-1959.2019.12.007]
 WANG Yong-yan,YU Zhao-hu.Design and Implementation of Antibacterial Drug Approval Management Software[J].Journal of Medical Information,2019,32(11):21.[doi:10.3969/j.issn.1006-1959.2019.12.007]
[5]王 蕊,陈金萍.2016~2017年脊柱手术预防用药及术后感染情况分析[J].医学信息,2018,31(24):112.[doi:10.3969/j.issn.1006-1959.2018.24.032]
 WANG Rui,CHEN Jin-ping.Analysis of Orophylactic Medication and Postoperative Infection in Spinal Surgery from 2016 to 2017[J].Journal of Medical Information,2018,31(11):112.[doi:10.3969/j.issn.1006-1959.2018.24.032]
[6]尹利娟,杨振华,杨乐园.2017年我院肠杆菌科细菌临床分布及耐药性分析[J].医学信息,2019,32(01):136.[doi:10.3969/j.issn.1006-1959.2019.01.042]
 YIN Li-juan,YANG Zhen-hua,YANG Le-yuan.Analysis of Clinical Distribution and Drug Resistance of Enterobacteriaceae in Our Hospital in 2017[J].Journal of Medical Information,2019,32(11):136.[doi:10.3969/j.issn.1006-1959.2019.01.042]
[7]王永宁,王瑞文,薛 郡,等.天津地区某基层医院铜绿假单胞菌的5年耐药变迁[J].医学信息,2019,32(09):124.[doi:10.3969/j.issn.1006-1959.2019.09.041]
 WANG Yong-ning,WANG Rui-wen,XUE Jun,et al.Five-year Resistance Change of Pseudomonas Aeruginosa in a Primary Hospital in Tianjin[J].Journal of Medical Information,2019,32(11):124.[doi:10.3969/j.issn.1006-1959.2019.09.041]
[8]彭洪兴.运用PDCA降低住院患者抗菌药物使用率及使用强度的临床实践[J].医学信息,2019,32(09):149.[doi:10.3969/j.issn.1006-1959.2019.09.049]
 PENG Hong-xing.Clinical Practice of Using PDCA to Reduce the Use Rate and Intensity of Antibiotics in Hospitalized Patients[J].Journal of Medical Information,2019,32(11):149.[doi:10.3969/j.issn.1006-1959.2019.09.049]
[9]樊凌燕,钱 鑫,熊世娟,等.2017年贵州省某综合型医院细菌耐药性监测及动态分析[J].医学信息,2019,32(10):136.[doi:10.3969/j.issn.1006-1959.2019.10.045]
 FAN Ling-yan,QIAN Xin,XIONG Shi-juan,et al.Monitoring and Dynamic Analysis of Bacterial Resistance in a General Hospital in Guizhou Province in 2017[J].Journal of Medical Information,2019,32(11):136.[doi:10.3969/j.issn.1006-1959.2019.10.045]
[10]顾万娟,李 亮,张 振,等.多重耐药菌的临床分布与耐药性分析[J].医学信息,2019,32(15):116.[doi:10.3969/j.issn.1006-1959.2019.15.038]
 GU Wan-juan,LI Liang,ZHANG Zhen,et al.Analysis of Clinical Distribution and Drug Resistance of Multi-drug Resistant Bacteria[J].Journal of Medical Information,2019,32(11):116.[doi:10.3969/j.issn.1006-1959.2019.15.038]

更新日期/Last Update: 2018-06-01